IBT
International Biotechnology Trust Portfolio holdings
AUM
$297M
This Quarter Return
+2.7%
1 Year Return
+17.25%
3 Year Return
+11.14%
5 Year Return
+79.35%
10 Year Return
–
AUM
$415M
AUM Growth
+$415M
(+9.5%)
Cap. Flow
+$33.4M
Cap. Flow
% of AUM
8.06%
Top 10 Holdings %
Top 10 Hldgs %
52.35%
Holding
76
New
10
Increased
22
Reduced
9
Closed
8
Top Buys
| 1 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
$14.4M |
| 2 |
Amgen
AMGN
|
$14.3M |
| 3 |
Illumina
ILMN
|
$10.9M |
| 4 |
Incyte
INCY
|
$9.18M |
| 5 |
Travere Therapeutics
TVTX
|
$8.73M |
Top Sells
| 1 |
Regeneron Pharmaceuticals
REGN
|
$17.8M |
| 2 |
Alnylam Pharmaceuticals
ALNY
|
$14M |
| 3 |
United Therapeutics
UTHR
|
$7.77M |
| 4 |
XLRN
Acceleron Pharma Inc.
XLRN
|
$7.59M |
| 5 |
Protagonist Therapeutics
PTGX
|
$6.81M |
Sector Composition
| 1 | Healthcare | 98.28% |